Navigation Links
BioNeutral Group Secures Three Initial Trial Orders for its Ogiene™ Odor Neutralizer & Multi-Purpose Cleaner Product Line
Date:3/8/2011

NEWARK, N.J. and LOUISVILLE, Ky., March 8, 2011 /PRNewswire/ -- BioNeutral Group, Inc. (OTC Bulletin Board: BONU), a specialty life science technology-based company, today announced that it has received three new initial trial orders for its highly diverse Ogiene™ line of unregulated products.

The initial orders were made by Indiana-based Oakland City University, Kentucky-based Grayson County Fiscal Court House, and Exceptional Teens and Adults (ETA), which is a structured program providing care and support to teens and adults that have been diagnosed with intellectual or developmental disabilities.

The orders, which resulted from the BioNeutral executive team's recent trip to Kentucky, are the first in what is expected to be a long-term relationship with BioNeutral and its game changing line of products, for each organization involved.

The Ogiene™ odor eliminating product line has received acclaim in life sciences circles for its ability to neutralize odors with a dramatic increase in speed and power over its rivals in the marketplace. Its multi-purpose cleaner and stain remover has repeatedly proven its effectiveness and ease of use in direct consumer based field trials. Ogiene's™ proprietary technology platform has been proven highly effective in both surface and airborne applications. Other formulas that will soon be introduced into the market are the Sport Odor Eliminator (for use on all sports equipment), Graffiti Remover and White Board Rejuvenator. All of the Ogiene™ products are environmentally safe and do not harm the worlds food supply.

This announcement continues to build on the momentum which BioNeutral has achieved since the beginning of the year. Last week, the company announced that the EPA has granted
'/>"/>

SOURCE BioNeutral Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioNeutral Group to Receive Economic Development Incentives
2. Kentucky Hospital Association Solutions Group Outlines Next Steps for BioNeutral Partnership
3. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing
4. BioNeutral Groups CEO, Stephen Browand and Chief Scientist, Dr. Andrew Kielbania to Appear on WVOX 1460 AM In Focus Radio Show Hosted by Dr. Dan Miller
5. BioNeutrals Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.
6. BioNeutrals Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms
7. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase
8. BioNeutral Signs Agreement With a Non-profit for Long-Term Removal of Formaldehyde to Save 10,000 Mobile Homes in Louisiana
9. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
10. Photonic Products Group, Inc. Announces New Sales and Marketing VP
11. NeoStem to Present at Cowen Group 31st Annual Health Care Conference on March 7 and 8
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... 2013 The JM Internet Group (web: ... has proudly announced that the company's YouTube channel on ... 175,000 views on YouTube. The company uses YouTube as ... tips and training for small businesses with much success. ... YouTube tips helpful for their SEO strategies", explained Jason ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Dr. Sparano ... and Women’s Health at the Albert Einstein College of ... at the Montefiore Medical Center. He is also ... Center and leads the Einstein Breast Cancer Working Group, ... translational breast cancer research. He also serves as Vice ...
(Date:5/17/2013)... transplant recipient,s immune system identifies the transplanted organ as ... that T cells, the immune cells that mediate rejection, ... in order to migrate to the transplanted organ. In ... , Fadi Lakkis and colleagues at the University of ... T cells is not required for migration. Instead, these ...
(Date:5/17/2013)... 17, 2013 - Elsevier, a world-leading provider of scientific, ... the publication of a recent study in ... blastocysts showing that those with an abnormal chromosomal composition ... have developed to blastocysts, thereby classifying the risk of ... the same group has undertaken a retrospective study, using ...
Breaking Biology Technology:YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Breakthrough for IVF? 2Breakthrough for IVF? 3
... and the public agree that the promise of nanotechnology is ... be governed accordingly. , The new technology, which is ... to computers, is seen differently among scientists than the general ... areas. But in broad categories of risk versus reward both ...
... N.Y., Feb. 15 EUSA Pharma (Oxford, UK), ... licensed OP-R003,a human anti-interleukin-6 antibody discovered by Vaccinex, ... product license, GSK will pay an up-front,license fee, ... the exclusive world-wide rights to develop and commercialize,OP-R003 ...
... Data presented at the 2008 Genitourinary Cancers ... OncoGenex Technologies Inc. announced,today that the Company,s ... as custirsen, was well-tolerated in combination with ... in patients with,hormone refractory prostate cancer. Additionally, ...
Cached Biology Technology:Nanotech's health, environmental impacts worry scientists and the public 2Nanotech's health, environmental impacts worry scientists and the public 3Vaccinex Antibody Licensed to GlaxoSmithKline 2OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 2OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 3OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 4
(Date:5/19/2013)... reports that white men and women of European descent ... and lesser toe deformities, including hammer or claw toe. ... the heritability of foot disorders in humansappear in ... Wiley on behalf of the American College of Rheumatology ... as 60% of older adults have foot disorders which ...
(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) explores ... and lifestyle. , Individuals suffering from Crohn,s ... fatigue and poor quality of life. These symptoms ... A randomized, double blind, placebo-controlled study found for ... to significant relief of these symptoms. , ...
(Date:5/17/2013)... Atlanta residents of all ages will celebrate the ... impact on our daily lives during the inaugural ... engineers and educators from local museums, corporations, K-12 ... than 40 different events for children and adults ... http://atlantasciencefestival.org . , The annual Atlanta ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3First Atlanta Science Festival set for 2014 2
... may emerge from a laboratory model that has just been ... human immune stem cells from umbilical cord blood into mice ... live alongside the mouse,s own immune system. Although mice ... causes typhoid fever, the bacteria are able to reproduce in ...
... Md. (September 22, 2010) The National Science Foundation ... Science Chesapeake Biological Laboratory $1.7 million to repair and ... Since 1936, the pier has played an instrumental role ... on climate change, fisheries management and the health of ...
... The antibacterial ingredient in some soaps, toothpastes, odor-fighting socks, ... long-sought new treatment for a parasitic disease that affects ... became the guiding light for future development of drugs ... Medicinal Chemistry . In the study, Rima McLeod ...
Cached Biology News:Humanized mice may provide clues to better prevent and treat typhoid fever 2Humanized mice may provide clues to better prevent and treat typhoid fever 3UMCES Chesapeake Biological Laboratory to rebuild historic research pier 2
Complete cell culture media with cytokines...
Request Info...
Contains 0.2 g/L EDTA4Na in phosphate-buffered saline....
... X-Gal ,MOLECULAR BIOLOGY GRADE ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C ... Cl N O 6 ,M.W.= ... ,Solution: Clear (2% in DMF) ,Biological ... and M13 ,Elemental Analysis: Agrees with ...
Biology Products: